Avatrombopag in the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure: a profile of its use in the USA Emma H. McCaffertyKatherine A. Lyseng-Williamson Adis Drug Q&A 08 December 2018 Pages: 1 - 6
Oxymetazoline 1% cream in erythema of rosacea: a profile of its use in the USA Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A 05 December 2018 Pages: 7 - 12
Erenumab in the prophylaxis of migraine: a profile of its use Emma H. McCaffertyKatherine A. Lyseng-Williamson Adis Drug Q&A 01 December 2018 Pages: 13 - 20
Pre-exposure prophylaxis for HIV infection may be effective in older candidates, but proceed with caution Adis Medical Writers Disease Management 21 September 2018 Pages: 21 - 23
Be cautious when treating gout in patients with renal impairment Adis Medical Writers Disease Management 23 October 2018 Pages: 24 - 28
Assessment of knowledge and practices of parents regarding childhood fever management in Kuala Lumpur, Malaysia Yu Hua HewAli Qais BlebilTahir Mehmood Khan Original Research Article 12 October 2018 Pages: 29 - 35
Comparison between aspirin 325 mg and enoxaparin 40 mg as extended thromboprophylactic agents following major orthopedic surgery in Jordan University Hospital Mariam Ahmed AlamiriAbla Mahmoud Albsoul-YounesJihad Moh’d Said Al-Ajlouni Short Communication 15 October 2018 Pages: 36 - 42
Severe skin rash associated with efavirenz and atazanavir: a case report in a rural health facility in Kenya K. Irungu Short Communication 03 November 2018 Pages: 43 - 45
Correction to: Anakinra in Still’s disease: a profile of its use Katherine A. Lyseng‑Williamson Correction Open access 17 November 2018 Pages: 46 - 46
Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU Katherine A. Lyseng-WilliamsonJürgen Behr Correction 23 November 2018 Pages: 47 - 47
Correction to: Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use Kate McKeageKatherine A. Lyseng-Williamson Correction 23 November 2018 Pages: 48 - 48
Correction to: Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use Katherine A. Lyseng-Williamson Correction Open access 28 November 2018 Pages: 49 - 49
Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its use Lesley J. Scott Correction Open access 27 December 2018 Pages: 50 - 50
